Navigation Links
Symposium Highlights Yale Study Indicating Role of AHCC(R) for Immune System Enhancement and as a Promising Cancer Preventative
Date:9/16/2008

AHCC in cancer therapy. Professor Emeritus Masuo Hosokawa of Hokkaido University gave an overview of the completed research on the effects of AHCC in reducing the side-effects of chemotherapy. The second keynote featured Professor Emeritus Yasuo Kamiyama of Kansai Medical University whose research investigated AHCC as a complementary therapy to pharmaceuticals in post-operative cancer patients along with cancer patients having additional complications.

A scientific review study soon to be published in the upcoming Nutritional Reviews Journal was presented by Dr. Barry Ritz of Drexel University's Department of Biotechnology. The paper gave an overview of the research studies -- published in peer-reviewed journals -- on the positive effect of AHCC on the influenza virus, the avian "bird flu" virus (H5N1), the West Nile virus, the Methicillin-Resistant Staphylococcus aureus (MRSA), the Klebsiella pnuemoniae and the Candida albicans viruses. It was reported that supplementation with AHCC modulated immunity and delivered positive results in response to acute infections.

"AHCC continues to demonstrate its essential role for healthy immune function," said Fred Pescatore, M.D., M.P.H., of the Center for Integrative and Complementary Medicine, and medical director for the U.S. AHCC Research Association in response to the research presented at this year's Symposium.

AHCC has been the subject of over 80 research studies worldwide including studies completed at Harvard University's Faulkner Hospital, Yale University and Columbia University Medical Center. Research has demonstrated that AHCC enhances the immune system by increasing the activity of white blood cells.

What is AHCC (Active Hexose Correlated Compound)?

AHCC is derived from the hybridization of several subspecies of medicinal mushroom, cultivated in Japan and then produced from a specialized manufacturing process. AHCC is the leading immune-enhancing supplement in Japan and is utili
'/>"/>

SOURCE AHCC Research Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium
2. International Symposium on Malignant Mesothelioma 2008
3. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
4. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
5. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
6. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
7. Clinical Impact of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) is Subject of Symposium at 16th Annual Scientific Congress of Hong Kong College of Cardiology
8. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
9. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
10. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
11. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015  AMRI (NASDAQ: ... a strategic collaboration focused on the development, manufacture ... pharmaceutical ingredients, ("APIs"). The collaboration combines Saneca,s strength ... expertise in developing and manufacturing controlled substance APIs ... tech transfer processes into these facilities. The collaboration ...
(Date:8/31/2015)... LAKE, N.J. and STAMFORD, Conn. ... U.S. pharmaceutical subsidiary of Eisai Co., Ltd., and Purdue ... a worldwide collaboration agreement for the development and commercialization ... dual orexin receptor antagonist entering Phase III clinical development ... the terms of the agreement, Eisai and Purdue Pharma ...
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
Breaking Medicine Technology:AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
... announces that a new market research report is ... Assist Devices - Global Pipeline Analysis, Opportunity Assessment ... http://www.reportlinker.com/p0330209/Cardiac-Assist-Devices---Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html Cardiac Assist Devices ... Forecasts to 2016 Summary ...
... The final hearing for approval of the class settlement ... by female sales representatives at Novartis Pharmaceutical Corporation is ... the courtroom of Judge Colleen McMahon of United States ... in Manhattan. The plaintiffs are seeking Court ...
Cached Medicine Technology:Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 4Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 5Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 6Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 7Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 8Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 9Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 10Reportlinker Adds Cardiac Assist Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 11Final Approval of Novartis Gender Discrimination Settlement Slated for November 19 2
(Date:8/31/2015)... ... August 31, 2015 , ... ... classes. , Starting September 1st they are offering pre and postnatal ... and "Healthy Body, Healthy Baby." , More information can be found at 248-601-6683. ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Coast ... Saturday, September 5, 2015, from 11 a.m. to 3 p.m. near Albertsons in the ... the opportunity to meet Dr. Ofelia Rivera and Dr. Jay Lopp. Call (760) 208-2518 ...
(Date:8/31/2015)... ... August 31, 2015 , ... In an article published ... Reconstructive Surgery Global Open Journal that discusses the future of 3-D printing technology as ... the future, customized implants, prosthetics, and other 3-D printed tools could be used to ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... Program at Monmouth, was one of the first doctors in the area to ... this new approach have been impressive: faster recovery, decreased immediate and long-term pain, ...
(Date:8/31/2015)... Scotch Plains, NJ (PRWEB) , ... August 31, 2015 , ... ... years as an “NJ Top Doc.” , At OSSMC, Dr. Kovatis treats all surgical ... general orthopedics and traumatic injuries to the entire musculoskeletal system, excluding the spine. , ...
Breaking Medicine News(10 mins):Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 3Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2
... Since antiquity, people have been fascinated with larger-than-life characters, ... Looking at the legions of fans mourning the loss ... a modern phenomenon. But from the gods on Olympus ... Sinatra in the 1950s to Brad and Angelina today, ...
... Continues as Growth of Company Exemplifies the Best in Retirement Living ... demand for senior housing will outpace supply in the coming years. Couple ... the future of the senior housing industry looks very different than it ... Aegis Living, a national leader in ...
... June 26 The Agency for Healthcare Research and Quality,s ... mixed reviews for the quality of care they provide. ... no state does well or poorly on all quality measures. ... Services is also releasing state-by-state reports on the health care ...
... deadlier than a heart attack, experts say, with chances for ... star Michael Jackson probably did not die on Thursday of ... sudden cardiac arrest, experts say. , It,s not yet clear ... Angeles home, but that assumption has been made by many ...
... , , Employers demonstrated commitment to making employee health ... 26 HealthFitness (NYSE Amex: FIT ) today ... as "2009 Best Employers for Healthy Lifestyles" by the National ... http://www.newscom.com/cgi-bin/prnh/20090122/CG61641LOGO ) , , According to the ...
... therapy, researchers say , FRIDAY, June 26 (HealthDay News) ... are more likely to have a level of arterial ... blood pressure, a new study finds. , Arterial stiffness ... high blood pressure. , The study provides new insight ...
Cached Medicine News:Health News:The Psychology of Celebrity Worship 2Health News:The Psychology of Celebrity Worship 3Health News:Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 2Health News:Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 3Health News:New Snapshots Show States Vary Widely in Providing Quality Health Care 2Health News:Jackson's Death Puts Spotlight on Sudden Cardiac Arrest 2Health News:Jackson's Death Puts Spotlight on Sudden Cardiac Arrest 3Health News:Several HealthFitness Clients Earn National Recognition for Employee Health Initiatives 2
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications....
FlexStationII offers the highest level of flexibility in developing functional cellular assays and analyzing real time kinetic data....
... Modulus™ is a multifunctional ... to give you utmost ... luminescence, and absorbance. Modulus ... fluorometer, dedicated luminometer, or ...
Medicine Products: